Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $118.6600 (-0.19%) ($118.0800 - $119.2400) on Wed. Nov. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | 57 | Latest Price | $118.6600(-0.19%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 0.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(35%) XLP(33%) VYM(31%) DIA(30%) | Factors Impacting ABBV price | ABBV will advance at least -0% in a week (0% probabilities). VIXM(-20%) UUP(-12%) IGOV(-4%) VXX(-1%) EDOC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0.8 () | Intraday Trend | -0% | | | |
|
5 Day Moving Average | $0(0%) | 10 Day Moving Average | $117.1(1.33%) | 20 Day Moving Average | $116.4(1.94%) | To recent high | -1.8% | To recent low | 11.5% | Market Cap | $209.35b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |